Axol Bioscience Acquires Phenocell to Advance Human Disease Models
21 Oct 2024 //
BUSINESSWIRE
Sygnature Discovery collaborates with Axol Bioscience
10 Oct 2023 //
PRESS RELEASE
Axol Collaborates With StrataStem to Deliver Stem Cell Based ‘Clinical Trial
07 Jun 2023 //
BUSINESSWIRE
Axol Bio Introduces CiPA-Validated Stem Cell-Derived Ventricular Cardiomyocytes
07 Jun 2022 //
BUSINESSWIRE
Axol Bioscience Raises £3.2 million GBP (c. $4.2 million USD)
07 Apr 2022 //
BUSINESSWIRE
Axol Bioscience and Censo Biotechnologies Announce Merger
17 Mar 2021 //
BIOSPACE
Axol Bioscience and CENSO Biotechnologies enter merger agreement
16 Mar 2021 //
PHARMAFILE